Chromosome Analysis,Chorionic Villus with Reflex to ClariSure®,Oligo-SNP,Prenatal
*Build Your Own Panel Eligible [?]
|
$1874
|
|
|
Description:
Testing determines chromosomal status of the fetus. Numerical and structural chromosomal abnormalities can be diagnosed. Sex and the presence of more than one cell line (mosaicism) can also be determined. Indications include diagnosis of chromosome abnormalities in fetuses of women who are of advanced maternal age; had a previous child with a chromosome abnormality; parental carrier of a balanced translocation, inversion or marker chromosome; parental mosaicism. Chromosomal Microarray, Prenatal, ClariSure® Oligo-SNP - This assay may be useful for: • Further investigation on fetuses with abnormal ultrasound findings indicating congenital malformation. • Further definition of an imbalanced cytogenetic abnormality. • Further investigation on equivocal cytogenetic findings. • Attempt at characterization of supernumerary marker chromosome. • Follow-up to a documented chromosome abnormality or genomic alteration in a sibling or a parent. • Family history of a previous child with mental retardation and/or phenotypic abnormalities.
Categories:
Price:
$1874
|
Chromosome Analysis, CLL/LPD
*Build Your Own Panel Eligible [?]
|
$1532
|
|
Description:
- Detect chromosome changes linked leukemia
- Monitor blood cancer disease progression
- Track genetic changes over time
Categories:
Price:
$1532
|
Chromosome Analysis, DEB Assay for Fanconi Anemia
*Build Your Own Panel Eligible [?]
|
$1406
|
|
|
Description:
This assay is a first-line screening test for patients with clinical suspicion of Fanconi anemia, an inherited disorder that causes chromosomal instability [1]. This test is not used to evaluate carrier status for Fanconi anemia or for prenatal testing.Fanconi anemia is a multigenic and primarily autosomal recessive disorder caused by pathogenic variants that affect DNA repair. Populations with increased carrier frequencies for 1 or more of these pathogenic variants include individuals of Ashkenazi Jewish, Afrikaner, sub-Saharan African, Roma, or South Asian (Indian and Pakistan) descent [1]. Clinical manifestations of Fanconi anemia vary broadly and may include congenital abnormalities, bone marrow failure, predisposition to cancer, and severe toxicity to chemotherapy. Early diagnosis is critical for patient management, especially in severe cases [1].This test evaluates chromosome breakage in cultured lymphocytes following treatment with diepoxybutane (DEB), a DNA cross-linking agent. Lymphocytes from patients with Fanconi anemia typically have an increased number of chromosomal breaks and aberrations. Clinical care guidelines for Fanconi anemia indicate that a positive test result should be followed by genetic testing to identify pathogenic variants; a negative test result with weak clinical suspicion may not require further testing; and an indeterminate (equivocal) result may be confirmed with a skin fibroblast chromosome breakage test [1].Although chromosome breakage analysis performed with peripheral blood is considered the gold standard for laboratory diagnosis of Fanconi anemia [1], other rare chromosome breakage disorders can also cause positive results. These include Nijmegen breakage syndrome, Roberts syndrome, and Warsaw breakage syndrome.The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.Reference1. Sroka I, et al, eds. Fanconi Anemia Clinical Care Guidelines. 5th ed. Fanconi Anemia Research Fund; 2020. Accessed April 19, 2022. https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf
Categories:
Price:
$1406
|
Chromosome Analysis, DEB Assay for Fanconi Anemia, Prenatal
*Build Your Own Panel Eligible [?]
|
$1888
|
|
Description:
- Screen unborn baby for genetic risk
- Detect inherited chromosome breakage patterns
- Assess family history related risks
Categories:
Price:
$1888
|
Chromosome Analysis, Hematologic Malignancy
*Build Your Own Panel Eligible [?]
|
$1923
|
|
|
Description:
Cytogenetics of hematologic disorders attempts to define and interpret chromosomal aberrations that occur in neoplastic cells associated with leukemia, lymphoma and other hematologic malignancies. Chromosome abnormalities in cancer cells of patients with malignant hematologic disorders including acute and chronic myeloid and lymphoid leukemias, myelodysplastic and myeloproliferative disorders, lymphomas and unexplained anemias may correlate with the diagnosis, prognosis, treatment and etiology of disease.
Categories:
Price:
$1923
|
Chromosome Analysis, Lymph Node
*Build Your Own Panel Eligible [?]
|
$1622
|
|
Description:
- Detect abnormal lymph node cell changes
- Screen for lymphoma related conditions
- Assess genetic patterns in swollen nodes
Categories:
Price:
$1622
|
Chromosome Analysis, Mosaicism
*Build Your Own Panel Eligible [?]
|
$1281
|
|
|
Description:
This chromosome study will examine 50 metaphase cells, whereas a standard chromosome analysis will examine 20 metaphase cells. This test for mosaicism is used to assess for constitutional chromosomal mosaicism or chimerism. While standard chromosome analysis can detect mosaicism ≥14%, this test can detect mosaicism ≥6% (at a 95% confidence level).
Categories:
Price:
$1281
|
Chromosome Analysis, POC Tissue with Reflex to Microarray
*Build Your Own Panel Eligible [?]
|
$2172
|
|
|
Description:
Chromosome analysis of products of conception (POC) can detect fetal chromosome abnormalities that are associated with approximately one-half of all first trimester spontaneous abortions. Since chromosome analysis on products of conception has an increased failure rate, this test will reflex to chromosomal microarray if chromosome analysis fails. Chromosomal microarray (CMA) detects aneuploidies, deletions and duplications below the resolution of chromosome analysis (karyotyping), and long continuous regions of homozygosity.
Categories:
Price:
$2172
|
Chromosome Analysis, Sister Chromatid Exchange (SCE) Assay for Bloom Syndrome
*Build Your Own Panel Eligible [?]
|
$1438
|
|
Description:
- Screen for rare inherited genetic condition
- Check chromosome repair and stability patterns
- Assess family cancer risk factors early
Categories:
Price:
$1438
|
Chromosome Analysis, Solid Tumor
*Build Your Own Panel Eligible [?]
|
$1759
|
|
Description:
- Analyze tumor cell genetic changes
- Assess cancer cell chromosome patterns
- Support your cancer care planning
Categories:
Price:
$1759
|
Chromosome Study, Blood (Slide Analysis)
*Build Your Own Panel Eligible [?]
|
$1574
|
|
Description:
- Detect chromosome abnormalities and genetic conditions
- Screen for hereditary fertility and pregnancy risks
- Assess developmental concerns linked to genetics
Categories:
Price:
$1574
|
Chronic Lymphocytic Leukemia (CLL) Prognostic Panel, Comprehensive
*Build Your Own Panel Eligible [?]
|
$4196
|
|
|
Description:
Chronic Lymphocytic leukemia is the most common leukemia in the Western world. The disease is chronic and most patients may not require therapy in the early stage of the disease. However, in some patients the disease can be aggressive and within a year the tumor mass may increase significantly imposing serious health problems to the patient. It is difficult to determine based on clinical presentation which patient will progress faster than the others. Therefore, there is a need to use more accurate prognostic indicator to predict the clinical course of this disease. The recent advances in CLL therapy and biology made it possible to develop new tests and a combination of these tests.
Categories:
Price:
$4196
|
Chronic Lymphocytic Leukemia (CLL) Prognostic Panel without Karyotype
*Build Your Own Panel Eligible [?]
|
$2811
|
|
|
Description:
Chronic Lymphocytic leukemia is the most common leukemia in the Western world. The disease is chronic and most patients may not require therapy in the early stage of the disease. However, in some patients the disease can be aggressive and within a year the tumor mass may increase significantly imposing serious health problems to the patient. It is difficult to determine based on clinical presentation which patient will progress faster than the others. Therefore, there is a need to use more accurate prognostic indicator to predict the clinical course of this disease. The recent advances in CLL therapy and biology made it possible to develop new tests and a combination of these tests (panel) provide more accurate information.
Categories:
Price:
$2811
|
Chronic Lymphocytic Leukemia, IgVH Mutation Status
*Build Your Own Panel Eligible [?]
|
$906
|
|
|
Description:
B cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia in the Western world. Patients with B-CLL follow heterogeneous clinical courses. Some patients survive for prolonged periods without requiring definitive therapy, while others have short survival despite aggressive treatment. Studies have established that patients might be divided into two groups based on the V gene mutation status. Patients with mutated V gene required minimal or no chemotherapy and had prolonged survival. Patients with unmutated V gene responded poorly to continuous multi-regimen chemotherapy and had shorter survival. The delineation of mutation status is based on the degree of homology to the germline sequence. A 98% homology (or 2% mutated sequence) cut-off was found to provide a good discrimination.
Categories:
Price:
$906
|
Chronic Urticaria Panel 1
*Build Your Own Panel Eligible [?]
|
$437
|
|
|
Description:
Chronic urticaria is a common skin disorder affecting 1% to 6% of the general population. It is characterized by repeated occurrence of short-lived cutaneous wheals accompanied by redness and itching. Autoimmune urticaria is defined by the presence of a functional IgG antibody to high-affinity IgE receptor (Fc epsilon RI alpha) or to IgE. These antibodies trigger mast cell and basophile degranulation by the engagement of Fc epsilon receptor. Functional IgG antibody to the receptor has been identified in approximately 30-40% of patients with chronic urticaria, and anti IgE antibody has been identified in another 5-10%.
Categories:
Price:
$437
|
Chronic Urticaria Panel 2 (Comprehensive)
*Build Your Own Panel Eligible [?]
|
$526
|
|
|
Description:
Patients with a chronic form of urticaria who are positive with the functional Histamine Release (Chronic Urticaria) test have an autoimmune basis for their disease. A positive result does not indicate which autoantibody (anti-IgE or anti-Fc epsilon RI alpha chain) is present. A positive anti-IgE antibody does not exclude the presence of anti-Fc epsilon RI alpha chain antibody. Autoimmune thyroid disease coexists in approximately 25% of autoimmune chronic urticaria patients.
Categories:
Price:
$526
|
Chronic Urticaria Panel 3
*Build Your Own Panel Eligible [?]
|
$504
|
|
|
Description:
Patients with a chronic form of urticaria who are positive with the functional Histamine Release (Chronic Urticaria) test have an autoimmune basis for their disease. A positive result does not indicate which autoantibody (anti-IgE or anti-Fc epsilon RI alpha chain) is present. A positive anti-IgE antibody does not exclude the presence of anti-Fc epsilon RI alpha chain antibody.
Categories:
Price:
$504
|
Chub Mackerel (f50) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against chub mackerel. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
Chymotrypsin, Stool
*Build Your Own Panel Eligible [?]
|
$329
|
|
|
Description:
The diagnosis of chronic pancreatitis depends upon the demonstration of functional impairment of the pancreas. Impairment is determined by several means, two of which are:1. Direct measurement of exocrine secretion into the duodenum after stimulation by a standard meal or after stimulation by intravenous secretin/pancreozymin.2. The direct measurement of the activities of certain enzymes in feces. Chymotrypsin activity in stool, for example, has been shown to be lower than normal in patients with pancreatic exocrine insufficiency.
Categories:
Price:
$329
|
Cinnamon (f220) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against cinnamon. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
Citalopram, Serum/Plasma
*Build Your Own Panel Eligible [?]
|
$422
|
|
Description:
- Check your citalopram medication levels
- Monitor antidepressant dosing accuracy
- Track medication changes over time
Categories:
Price:
$422
|
Citric Acid, 24-Hour Urine with Creatinine
*Build Your Own Panel Eligible [?]
|
$560
|
|
|
Description:
This quantitative citric acid test, performed with a 24-hour urine specimen, may help assess the risk of calcium stone formation in the kidneys and inform patient management [1]. In general, 24-hour urine specimens are preferred to random urine specimens when measuring citric acid for diagnostic evaluation and monitoring of calcium nephrolithiasis [2]. Because daily urine excretion of creatinine fluctuates little, creatinine excretion can help determine if 24-hour urine specimens for citric acid have been completely and accurately collected [1].Citrate inhibits calcium stone formation by binding and solubilizing calcium, which reduces supersaturation of calcium salts [1-2]. Approximately half of the patients with calcium stones have decreased urinary citrate levels [1]. Citrate is among several substances routinely screened to evaluate the risk of forming kidney stones. Low urinary citrate levels may indicate oral citrate treatment in patients with recurrent calcium nephrolithiasis [1]. Other conditions that can cause hypocitraturia include distal renal tubular acidosis, malabsorption, and urinary tract infection [1].The urinary citric acid level cannot be used to estimate dietary intake because other factors, such as acid-base balance, may affect citrate excretion [2].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Delaney, PM et al. Kidney disease. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.2. Williams JC Jr, et al. Urolithiasis. 2021;49(1):1-16.
Categories:
Price:
$560
|
Citric Acid, 24-Hour Urine without Creatinine
*Build Your Own Panel Eligible [?]
|
$556
|
|
|
Description:
This quantitative citric acid test, performed with a 24-hour urine specimen, may help assess the risk of calcium stone formation in the kidneys and inform patient management [1]. In general, 24-hour urine specimens are preferred to random urine specimens when measuring citric acid for diagnostic evaluation and monitoring of calcium nephrolithiasis [2].Citrate inhibits calcium stone formation by binding and solubilizing calcium, which reduces supersaturation of calcium salts [1-2]. Approximately half of the patients with calcium stones have decreased urinary citrate levels [1]. Citrate is among several substances routinely screened to evaluate the risk of forming kidney stones. Low urinary citrate levels may indicate oral citrate treatment in patients with recurrent calcium nephrolithiasis [1]. Other conditions that can cause hypocitraturia include distal renal tubular acidosis, malabsorption, and urinary tract infection [1].This test is also available with creatinine (Citric Acid, 24-Hour Urine with Creatinine). Because daily urine excretion of creatinine fluctuates little, creatinine excretion can help determine if 24-hour urine specimens for citric acid have been completely and accurately collected [1].The urinary citric acid level cannot be used to estimate dietary intake because other factors, such as acid-base balance, may affect citrate excretion [2].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Delaney, PM et al. Kidney disease. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.2. Williams JC Jr, et al. Urolithiasis. 2021;49(1):1-16.
Categories:
Price:
$556
|
Citric Acid, Serum
*Build Your Own Panel Eligible [?]
|
$349
|
|
Description:
- Screen for kidney stone risk
- Check your metabolic energy balance
- Track mineral and hydration levels
Categories:
Price:
$349
|
Citric Acid, Urine with Creatinine
*Build Your Own Panel Eligible [?]
|
$560
|
|
|
Description:
This quantitative citric acid test, performed with a random urine specimen, may help assess the risk of calcium stone formation in the kidneys and inform patient management [1]. In general, 24-hour urine specimens (Citric Acid, 24-Hour Urine with Creatinine) are preferred to random urine specimens when measuring citric acid for diagnostic evaluation and monitoring of calcium nephrolithiasis [2].Citrate inhibits calcium stone formation by binding and solubilizing calcium, which reduces supersaturation of calcium salts [1-2]. Approximately half of the patients with calcium stones have decreased urinary citrate levels [1]. Citrate is among several substances routinely screened to evaluate the risk of forming kidney stones. Low urinary citrate levels may indicate oral citrate treatment in patients with recurrent calcium nephrolithiasis [1]. Other conditions that can cause hypocitraturia include distal renal tubular acidosis, malabsorption, and urinary tract infection [1].The urinary citric acid level cannot be used to estimate dietary intake because other factors, such as acid-base balance, may affect citrate excretion [2].The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.References1. Delaney, PM et al. Kidney disease. In: Rifai R, et al. eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier Inc; 2022.2. Williams JC Jr, et al. Urolithiasis. 2021;49(1):1-16.
Categories:
Price:
$560
|
c-KIT Mutation Analysis, Cell Based
*Build Your Own Panel Eligible [?]
|
$1932
|
|
|
Description:
Activating c-KIT mutations have been indentified in various human cancers. c-KIT exon 8 and 17 mutations have been described in patients with CBF-AMLs and usually confer a poor prognosis with increased relapse rate. c-KIT exon 9, 11, 13, 17 mutations have been reported in nearly 90% GIST patients. The presence mutation usually predict poor survival. c-KIT exon 17 mutation has been reported in patients with systemic mastocytosis.
Categories:
Price:
$1932
|
c-KIT Mutations with Reflex to PDGFRA Mutations for GIST
*Build Your Own Panel Eligible [?]
|
$1932
|
|
|
Description:
Eighty percent of patients with gastrointestinal stromal tumor (GIST) have a C-KIT mutation in exon 9, 11, 13, or 17. The presence of a mutation usually predicts poor survival. Patients with C-KIT mutations other than D816V are likely to respond to imatinib (Gleevec) therapy. Mutations in the PDGFRA gene are found in about 7% of gastrointestinal stromal tumors (GISTs), especially in KIT wild type GISTs. PDGFRA mutations also have been described in synovial sarcomas (SSs) and malignant peripheral nerve sheath tumors (MPNST). GISTs with PDGFRA mutations (except D842V) are likely to respond to imatinib.
Categories:
Price:
$1932
|
CK-MB (CK-2)
*Build Your Own Panel Eligible [?]
|
$220
|
|
Description:
- Measures heart muscle damage.
- Checks for heart attack signs.
- Assesses heart health status.
Includes:
CK-MB (CK-2)
Categories:
Price:
$220
|
CKR-5 Gene, DNA Mutation Analysis
*Build Your Own Panel Eligible [?]
|
$522
|
|
|
Description:
The CKR-5 gene encodes a protein critical for HIV-1 infection. Patients who are heterozygous for a deletion of the CKR-5 gene have prolonged AIDS-free survival. Patients with two defective copies are resistant to HIV-1 infection.
Categories:
Price:
$522
|
Cladosporium herbarum (m2) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This allergen-specific IgE antibody test quantifies an individual’s IgE response to Cladosporium herbarum. It is an in vitro quantitative assay that is intended to be used in conjunction with other clinical information to aid in the diagnosis of allergic diseases [1]. While allergen-specific serum IgE testing is considered comparable to skin testing in many instances, both the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology recognize that allergen-specific serum IgE testing may be preferred in some clinical situations. These include 1) the presence of widespread skin disease, 2) the recent use of antihistamines or other medications that can affect the results of allergy skin tests, 3) uncooperative patients, and 4) medical history suggesting that allergen skin testing would pose a significant risk for a serious allergic reaction [1]. A definitive clinical diagnosis of allergy should not be based on the results of any single diagnostic method, but should be made by a trained healthcare provider after all clinical and laboratory findings have been evaluated. More specific information about this allergen can be found at http://www.phadia.com/en/products/allergy-testing-products/immunocap-allergen-information/molds-and-other-microorganisms/allergens/cladosporium-herbarum-/ Reference 1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(Suppl 3):S1-S148.
Categories:
Price:
$49
|
Cladosporium herbarum (m2) IgG
*Build Your Own Panel Eligible [?]
|
$118
|
|
Description:
- Detect mold allergy trigger sources
- Check sneezing and congestion causes
- Assess indoor air exposure risks
Categories:
Price:
$118
|
Cladosporium/hormodendrum IgG4
*Build Your Own Panel Eligible [?]
|
$254
|
|
Description:
- Check mold allergy sensitivity levels
- Detect indoor mold exposure reactions
- Screen recurring sinus and cough symptoms
Categories:
Price:
$254
|
Clam (f207) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against clams. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
Clindamycin Resistance Test, (D Test)
*Build Your Own Panel Eligible [?]
|
$86
|
|
|
Description:
Some isolates of Staphylococcus species Streptococcus Pneumoniae and beta-hemolytic Streptococci have been shown to have inducible resistance to clindamycin. Treatment of a patient with clindamycin for an organism that has inducible clindamycin resistance (D Test positive) may result in treatment failure.
Categories:
Price:
$86
|
CLL Mutation Analysis Only
*Build Your Own Panel Eligible [?]
|
$836
|
|
|
Description:
Helps physicians diagnose and predict the course of disease progression for hematologic diseases.
Categories:
Price:
$836
|
CLL Profile
*Build Your Own Panel Eligible [?]
|
$3080
|
|
|
Description:
Helps physicians diagnose and predict the course of disease progression for hematologic diseases.
Categories:
Price:
$3080
|
Clomipramine
*Build Your Own Panel Eligible [?]
|
$300
|
|
|
Description:
Clomipramine and its active metabolite, norclomipramine are antidepressant drugs. Therapeutic drug monitoring is useful to optimize dose and to avoid toxicity.
Categories:
Price:
$300
|
Clonazepam
*Build Your Own Panel Eligible [?]
|
$354
|
|
|
Description:
Clonazepam is a benzodiazepine used as a tranquilizer. Clonazepam is used in treating patients with seizures and in reducing tardive dyskinesia. Therapeutic drug monitoring is useful to avoid toxicity.
Categories:
Price:
$354
|
Clorazepate (Tranxene®)
*Build Your Own Panel Eligible [?]
|
$291
|
|
|
Description:
Orally administered clorazepate is rapidly decarboxylated to its metabolite, nordiazepam. There is essentially no circulating patent drug. Nordiazepam elimination half-life is about 40 to 50 hours. Plasma levels of nordiazepam increase proportionally with clorazepate dose and show moderate accumulation with repeated administration.
Categories:
Price:
$291
|
Clostridium difficile Culture with Reflex to Toxin B, Real-Time PCR,Isolate
*Build Your Own Panel Eligible [?]
|
$282
|
|
|
Description:
C. difficile causes 50-75% of antibiotic associated colitis and greater than 90% of antibiotic associated pseudomembranous colitis. Pathogenic C. difficile produce two potent toxins, toxin A and toxin B, that cause diarrhea and colitis.
Categories:
Price:
$282
|
Clostridium difficile Cytotoxicity Assay
*Build Your Own Panel Eligible [?]
|
$320
|
|
|
Description:
Clostridium difficile is a spore-forming bacteria that is part of the normal intestinal flora. With intestinal overgrowth, c. Difficile is the major cause of antibiotic-associated diarrhea and colitis. C. Difficile is the primary cause of pseudomembranous colitis. The organism produces cytotoxins that lead to frequent, foul-smelling, watery stools.
Categories:
Price:
$320
|
Clostridium difficile Toxin B, Qualitative, Real-Time PCR
*Build Your Own Panel Eligible [?]
|
$289
|
|
|
Description:
C. difficile is the major cause of antibiotic-associated diarrhea (AAD) and pseudomembranous colitis.
Categories:
Price:
$289
|
Clostridium difficile Toxin/GDH with Reflex to PCR
*Build Your Own Panel Eligible [?]
|
$342
|
|
|
Description:
You must go to Quest to pick up a the collection container.
Collect fresh stool in sterile, leak-proof container without media, preservative, or metal ion.
Freeze specimen and return to lab.
Includes:
Clostridium difficile Toxin/GDH with Reflex to PCR
Categories:
Price:
$342
|
Clove (f268) IgE
*Build Your Own Panel Eligible [?]
|
$49
|
|
|
Description:
This test detects the presence of specific IgE against clove. A positive test only indicates that a person is sensitized and potentially allergic to this allergen. A diagnosis of allergy requires clinical signs and symptoms that appear to be associated with exposure to the allergen in addition to the detection of markers of IgE sensitization [1].More specific information about this allergen can be found on the following website: https://www.thermofisher.com/phadia/us/en/resources/allergen-encyclopedia.htmlReference1. Bernstein IL, et al. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
Categories:
Price:
$49
|
Clozapine
*Build Your Own Panel Eligible [?]
|
$315
|
|
|
Description:
Clozapine is an atypical antipsychotic agent. Norclozapine has minimal therapeutic activity.
Categories:
Price:
$315
|
C-MYC, IHC with Interpretation
*Build Your Own Panel Eligible [?]
|
$442
|
|
|
Description:
Oncoprotein expressed in a variety of tumors including Burkitt lymphoma and some diffuse large B cell lymphomas.
Categories:
Price:
$442
|
C-MYC, IHC without Interpretation
*Build Your Own Panel Eligible [?]
|
$370
|
|
|
Description:
Oncoprotein expressed in a variety of tumors including Burkitt lymphoma and some diffuse large B cell lymphomas.
Categories:
Price:
$370
|
Cobalt
*Build Your Own Panel Eligible [?]
|
$322
|
|
Description:
- Screen for metal exposure risks
- Check joint implant safety levels
- Monitor workplace toxin buildup
Categories:
Price:
$322
|
Cobalt, 24-Hour Urine
*Build Your Own Panel Eligible [?]
|
$283
|
|
|
Description:
Cobalt is part of our diet. Approximately 85% of absorbed cobalt is excreted in the urine and the remainder eliminated in stool. Toxicity may occur in select industrial environments. Cobalt is not mined in the United States so primary supplies are imported.
Categories:
Price:
$283
|
Cobalt, Blood
*Build Your Own Panel Eligible [?]
|
$295
|
|
Description:
- Measures cobalt levels in blood.
- Checks for cobalt exposure.
- Monitors cobalt-related health issues.
Includes:
Cobalt, Blood
Patient Instructions:
Patient should refrain from taking mineral supplements, vitamin B12 or vitamin B complex 3 days prior to specimen collection.
Categories:
Price:
$295
|